Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

Stress-related hair loss was reversed with a special medication.

New treatments for child hair loss due to immune issues are effective but not yet officially approved.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Anorexia Nervosa and Bulimia Nervosa are complex eating disorders with increasing incidence among young females, significant morbidity, and varying mortality rates, requiring more research for better treatment.

AI and advanced technologies are improving medical diagnostics and treatments.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Vitiligo is often found with other autoimmune diseases, which is important to know to help patients.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Alopecia areata treatment varies, with no optimal method established yet.

Hair growth is influenced by various body and external factors, and neighboring hairs communicate to synchronize regeneration.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Alopecia areata progression is linked to stress and hormone changes, suggesting new treatment targets.

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

Hair follicles in nonsegmental vitiligo are better protected from immune attacks than in alopecia areata.

Improving CRISPR/Cas systems can make gene editing more efficient and precise.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

Damaged skin has a weakened barrier, making it more vulnerable to substances and inflammation.

Different immune cells like platelets, mast cells, neutrophils, macrophages, T cells, B cells, and innate lymphoid cells all play roles in skin wound healing, but more research is needed due to inconsistent results and the complex nature of the immune response.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.